Viewing Study NCT02862132

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2026-05-15 @ 6:47 PM
Study NCT ID: NCT02862132
Status: COMPLETED
Last Update Posted: 2022-10-25
First Post: 2016-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases
Sponsor: Shaare Zedek Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Crohn's Disease View
None Ulcerative Colitis View
None Inflammatory Bowel Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None VDZ: Vedolizumab View
None UC: Ulcerative colitis View
None CD: Crohn's disease View
None TDM: Therapeutic drug monitoring View